UnitedHealthcareMedicaid · Coverage · Medical Benefit Drug Policy · AZMedium impact
Denied Drug Codes – Pharmacy Benefit Drugs (for Arizona Only)
Act
by Oct 1, 2026
Effective date
Oct 1, 2026
Identified
Sep 2, 2026
Summary
UnitedHealthcare Community Plan of Arizona is denying payment for two specialty drugs (Lamzede [J0217] and Zevaskyn [J3389]) when billed on medical professional or outpatient facility claims. These injectable medications must now be reimbursed exclusively through the outpatient pharmacy benefit to comply with Arizona's Catastrophic Reinsurance Program requirements.
Get alerts when payers change rules like this one
We check UnitedHealthcare and other payers every day and email you when a change matches your specialty and state.
01Billing team must update claim routing logic in billing system to ensure HCPCS codes J0217 (Lamzede) and J3389 (Zevaskyn) are submitted ONLY on pharmacy benefit claims for Arizona UnitedHealthcare Community Plan members.
02Remove these codes from medical professional claim forms (CMS-1500) and outpatient facility claim forms (UB-04) to prevent automatic denials.
03Communicate to providers and clinical staff that these specialty drugs cannot be billed through medical claims.
04Claims submitted on medical/facility forms for J0217 or J3389 will be denied and require rebilling through pharmacy channels.
Codes mentioned
J0217J3389
Original notice
Denied Drug Codes – Pharmacy Benefit Drugs (for Arizona Only)
uhcprovider.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.